BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $27.5 million versus the consensus estimate of $25.68 million.

GUIDANCE:

BioLife Solutions sees FY2026 revenue of $112.5-115 million, versus the consensus of $112.9 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.